Proposals for a Phenotypic Classification of B-Chronic Lymphocytic Leukemia, Relationship with Prognostic Factors

References

• Merle-Beral H., Blanc C., Chastang C., Debre P. Phenotypic heterogeneity of B and T cell differentiation antigens in B CLL. Eur. J. Haematol. 1988; 41: 197–203
   PubMed Web of Science ®Google Scholar
• Boumsell L., Bernard A., Lepage V., Degos L., Lemerle J., Dausset J. Some chronic lymphocytic leukemia cells bearing surface immunoglobulin share determinants with T cells. Eur. J. Immunol. 1978; 8: 900–904
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gobbi M., Janossy G. Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J. Exp. Med. 1982; 155: 623–628
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Boyd A. W., Bieber F. R., Daley J. F., Rosen K. J., Horowitz J. C., Levy D. N., Nadler L. M. Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 1987; 70: 418–425
   PubMed Web of Science ®Google Scholar
• Delia D., Cattoretti G., Polli N., Fontanella E., Aiello A., Giardini R., Rilke F., Della Porta G. CD1c but neither CD1a nor CD1b are expressed on normal activated and malignant human B cells: identification of a new B cell subset. Blood 1988; 72: 241–247
   PubMed Web of Science ®Google Scholar
• Merle-Beral H., Boumsell L., Michel A., Debre P. CD1 expression on B CLL lymphocytes. Br. J. Haematol. 1989; 71: 209–212
   PubMed Web of Science ®Google Scholar
• Small T. N., Knowles R. W., Keever C., Kernan N. A., Collins N., O'Reilly R. J., Dupont B., Flomenberg N. M241 (CD1) expression on B lymphocytes. J. Immunol. 1987; 138: 2864–2868
   PubMed Web of Science ®Google Scholar
• Durandy A., Thuillier L., Forveille M., Fischer A. Phenotypic and functional characteristics of newborns' B lymphocytes. J. Immunol. 1990; 144: 60–64
   PubMed Web of Science ®Google Scholar
• Freedmann A. S., Boyd A. W., Berrebi A., Horowitz J. C., Levy D. N., Rosen K. J., Daley J. F., Slaughenhoupt B., Levine H., Nadler L. M. Expression of B cell activation antigens on normal and malignant B cells. Leukemia 1987; 1: 9–18
   PubMed Web of Science ®Google Scholar
• Nadler L. M. B cell leukemic panel workshop: summary and contents. Leukocyte Typing II Human B lymphocyte, E. D. Reinherz, B. F. Hayne, L. M. Nadler, I. D. Bernstein. Springer-Verlag, New York 1986; 2–47
   Google Scholar
• Morabito F., Prasthofer E. F., Dunlap N. E., Grossi C. E., Tilden A. B. Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. Blood 1987; 70: 1750–1757
   PubMed Web of Science ®Google Scholar
• Pinto A., Zagonel V., Carbone A., Del Vecchio L., Marotta G., Tirelli V., Roncadin M., Monfardini S., Colombatti A. Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells identifies a subset of patients with a “variant” CLL phenotype and different biological and clinical features. In Proceedings of American Society of Clinical Oncology. 1989, 204, (abstr)
   Google Scholar
• Wormsley S. B., Baird S. M., Gadol N, Rai K. R., Sobol R. E. Characteristics of CD11c+ CD5+ chronic B cell leukemias and identification of a novel peripheral blood B cell subset with chronic lymphoid leukemia immunophenotypes. Blood 1990; 76: 123–129
   PubMed Web of Science ®Google Scholar
• Montserrat E., Sanchez-Bisono J., Vinolas N., Rozman C. Lymphocyte doubling time in chronic lymphocytic leukemia: analysis of its significance. Br. J. Haematol. 1986; 62: 567–575
   PubMed Web of Science ®Google Scholar
• Catovsky D., Cherchi M., Brooks D., Bredley J., Zola H. Heterogeneity of B cell leukemia demonstrated by the monoclonal antibody FMC7. Blood 1981; 58: 406–408
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Freeman G., Whitman J., Segil J., Daley J., Levine H., Nadler L. M. Expression and regulation of CD5 on in vitro activated human B cells. Eur. J. Immunol. 1989; 19: 849–854
   PubMed Web of Science ®Google Scholar
• Theodorou I., Boumsell L., Calves C. F., Gouy H., Merle-Beral H., Debre P. CD1 stimulation of human T cell line induces a rapid increase in the intracellular free Ca++ concentration and the production of IL2. J. Immunol. 1990; 144: 25–38
   Web of Science ®Google Scholar
• Medeiros L. J., Picker L. J., Horning S., Warnke R. A. Transferring receptor expression by non-Hodgkin's lymphomas. Cancer 1988; 61: 1844–1851
   PubMed Web of Science ®Google Scholar
• Faure G. C., Bene M. C., Bolle-Chanal M. H. Expression of CD25 (Tac antigen) in lymphoid leukemias and non-Hodgkin's lymphomas. Eur. J. Haematol. 1987; 38: 26–30
   PubMed Web of Science ®Google Scholar
• Totterman T. H., Carlsson M., Larsson L., Forsbeck K., Danersund A., Nilsson K. Chronic lymphocytic leukemia, recent progress and future direction. Liss, London 1987; 29–37
   Google Scholar
• Gordon J., Guy G. The molecules controlling B lymphocytes. Immunol. Today 1987; 81: 339–343
   Google Scholar
• Kipps T. J., Vaughan J. H. Genetic influence on the levels of circulating CD5 B lymphocytes. J. Immunol. 1987; 139: 1060–1064
   PubMed Web of Science ®Google Scholar
• Pallessen G., Hamilton-Dutoit S., Plesner T. LFA-1 in lymphomas: absence in hairy cell leukemia. An analysis of the workshop panel of CD11/18 clustered antibodies. Leukocyte typing IV, W. Knapp, B. B. Dorigen, W. R. Gilics, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. Von Dem Borne. Oxford University Press, Oxford 1989; 553–554
   Google Scholar
• Flandrin G. Hairy cell leukemia: hematological and clinical comparison with other chronic B-cell leukemias. Lecture to the European School of Hematology. Paris 1988, 1988
   Google Scholar
• Drexler H., Brenner M., Gignac S., Hoffbrand A. V. Expression of tartrate resistant acid phosphatase in B CLL treated with phorbol ester or phorbol ester plus calcium ionophore. Eur. J. Haematol. 1988; 41: 250–257
   PubMed Web of Science ®Google Scholar
• Miller L. J., Schwarting R., Springer T. A. Regulated expression of the MAC-1, LFA-1, p150/95 glycoprotien family during leukocyte differentiation. J. Immunol. 1986; 137: 2891–2900
   PubMed Web of Science ®Google Scholar
• Zola H., Furness V., Nikoloutsopoulos A., Neoh S. H., Barclay S., Starr R., Day A., Russ G. R. The LFA-1 antigen in human B lymphocyte activation. Disease Markers 1989; 7: 95–104
   PubMed Web of Science ®Google Scholar
• Inghirami G., Wieczorek R., Zhu B. Y., Silber R., Dalla-Favera R., Knowles D. M. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988; 72: 1431–1434
   PubMed Web of Science ®Google Scholar